# US 2013/0295199 A1 · Composition Comprising OPC and Omega-3 for Preventing and/or Inhibiting the Development of Diabetic Retinopathy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0295199 A1
- Document ID: US20130295199A1
- Status: Published application
- Kind: A1
- Application number: 13/979,633
- Filed: 2012-01-13
- Published: 2013-11-07
- Earliest claimed: 2011-01-14
- Assignees: Visiotact Pharma
- Inventors: Reda Hadj-Slimane; Yves Lepelletier; Tewfik Hadj-Slimane
- Web page: https://patentgrep.com/patent/US20130295199A1

## CPC

- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 31/4415: Pyridoxine, i.e. Vitamin B6 (pyridoxal phosphate A61K31/675)
- A61K 31/51: Thiamines, e.g. vitamin B1
- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 36/15: Pinaceae (Pine family), e.g. pine or cedar
- A61P 27/02: Ophthalmic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention relates to a composition comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids, for use in preventing or stabilizing the development and/or the progression of a diabetes-related eye condition in a subject; this invention includes a functional food, a nutraceutical composition or a food or dietary supplement comprising said composition; this invention also relates to a pharmaceutical composition or a veterinarian product comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A method of treating a subject comprising:
obtaining at least one oligoproanthocyanidin (OPC) and at least one omega-3 fatty acid; and
administering the OPC and omega-3 fatty acid to a subject;
wherein development and/or progression of a diabetes-related eye condition is prevented or stabilized in the subject.

### Claim 21 (depends on 20)

The method of claim 20, wherein the OPC and omega-3 fatty acid are comprised in a composition prior to administration.

### Claim 22 (depends on 20)

The method of claim 20, further comprising administering at least one vitamin or inorganic compound to the subject.

### Claim 23 (depends on 22)

The method of claim 22, further comprising administering at least one B vitamin to the subject.

### Claim 24 (depends on 22)

The method of claim 22, further comprising administering at least one mineral to the subject.

### Claim 25 (depends on 20)

The method of claim 20, further comprising administering at least one of vitamin B1, vitamin B6, chromium, or magnesium to the subject.

### Claim 26 (depends on 25)

The method of claim 25, wherein vitamin B1 is administered as at least one of thiamin or benfotiamin.

### Claim 27 (depends on 25)

The method of claim 25, wherein vitamin B6 is administered as at least one of pyridoxamine, pyridoxal, or pyridoxine.

### Claim 28 (depends on 25)

The method of claim 25, wherein chromium is administered as at least one of chromium picolinate, chromium chloride, chromium GTF®, or chromium polynicotinate.

### Claim 29 (depends on 25)

The method of claim 25, wherein magnesium is administered as at least one of magnesium gluconate, magnesium citrate, magnesium chloride, magnesium malate, magnesium orotate, or magnesium from the sea.

### Claim 30 (depends on 25)

The method of claim 25, further comprising administering OPC, omega-3 fatty acids, vitamin B1, vitamin B6, chromium, and magnesium to the subject.

### Claim 31 (depends on 20)

The method of claim 20, wherein the OPC is natural, synthetic or hemisynthetic.

### Claim 32 (depends on 20)

The method of claim 20, wherein the OPC is natural and the composition comprises as OPC an OPC-containing natural extract.

### Claim 33 (depends on 32)

The method of claim 32, wherein the OPC-containing natural extract is a vegetal extract.

### Claim 34 (depends on 33)

The method of claim 33, wherein the OPC-containing natural extract is an extract from a plant of the Pinacae family.

### Claim 35 (depends on 20)

The method of claim 20, wherein the omega-3 fatty acid comprises at least one of DHA or EPA.

### Claim 36 (depends on 20)

The method of claim 20, further comprising administering a fish oil containing DHA to the subject.

### Claim 37 (depends on 20)

The method of claim 20, wherein the diabetes-related eye condition is a condition of the interior of the eye.

### Claim 38 (depends on 37)

The method of claim 37, wherein the diabetes-related eye condition is glaucoma or a retinal condition.

### Claim 39

A composition comprising at least one OPC and at least one omega-3 fatty acid.

### Claim 40 (depends on 39)

The composition of claim 39, further defined as a functional food, nutraceutical composition, or a food or dietary supplement.

### Claim 41 (depends on 40)

The composition of claim 40, further defined as a functional food, nutraceutical composition or a food or dietary supplement, comprising:
1 to 200 mg of OPC, or 1.5 to 300 mg of a natural extract containing OPC;
100 to 250 mg of DHA, or 10 to 1000 mg of a fish oil containing DHA;
0 to 10 mg of vitamin B1;
0 to 10 mg of vitamin B6;
0 to 500 μg of chromium; and
0 to 1000 mg of magnesium.

### Claim 42 (depends on 40)

The composition of claim 40, further defined as a medicament and/or veterinarian product.

### Claim 43 (depends on 40)

The composition of claim 40, further defined as comprised in a pharmaceutically acceptable excipient.
